Point72 Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,400
Closed -$486K 4618
2025
Q4
$486K Buy
+5,400
New +$512K ﹤0.01% 3245
2023
Q4
Sell
-600
Closed -$67.3K 2938
2023
Q3
$67.3K Buy
+600
New +$76.2K ﹤0.01% 2063
2018
Q3
Sell
-206,000
Closed -$22.3M 1250
2018
Q2
$22.3M Buy
+206,000
New +$22.4M 0.09% 276
2018
Q1
Sell
-103,000
Closed -$12.1M 1158
2017
Q4
$12.1M Buy
+103,000
New +$11.6M 0.05% 408
2017
Q3
Sell
-77,250
Closed -$9.63M 1085
2017
Q2
$9.63M Buy
+77,250
New +$9.16M 0.05% 392

Other funds holding ZBH

Point72 Asset Management's ZBH Position: Q1 2026 in Review

Point72 Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 63,373 shares — an estimated $5.7M sold.

Point72 Asset Management first reported a position in ZBH in Q2 2014 and held it in 32 quarters. The position peaked at $238M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Point72 Asset Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 63,373 Zimmer Biomet shares in Q1 2026, an estimated $5.7M.
  • Point72 Asset Management first reported a position in Zimmer Biomet in Q2 2014 and held it in 32 quarters.
  • Point72 Asset Management's Zimmer Biomet position peaked at $238M in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.